Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Classification of anticancer drugs: an update with FDA- and EMA-approved drugs ; day:5 ; month:7 ; year:2024 ; pages:1-11
Cancer and metastasis reviews ; (5.7.2024), 1-11

Creator: Ostios-Garcia, Lorena
Pérez, Daniel Martínez
Castelo, Beatriz
Herradón, Noelia Hernández
Zamora, Pilar
Feliu, Jaime
Espinosa, Enrique

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10555-024-10188-5

URN: urn:nbn:de:101:1-2409232102466.175228949956

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ostios-Garcia, Lorena
Pérez, Daniel Martínez
Castelo, Beatriz
Herradón, Noelia Hernández
Zamora, Pilar
Feliu, Jaime
Espinosa, Enrique
SpringerLink (Online service)

Other Objects (12)

A systematic analysis of FDA-approved anticancer drugs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Hochschulschrift

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

A systematic analysis of FDA-approved anticancer drugs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Hochschulschrift

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

A systematic analysis of FDA-approved anticancer drugs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Hochschulschrift

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A systematic analysis of FDA-approved anticancer drugs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

A systematic analysis of FDA-approved anticancer drugs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

A systematic analysis of FDA-approved anticancer drugs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Related objects

Reset password